Enhanced matrix degradation after withdrawal of TGF-β1 triggers hepatocytes from apoptosis to proliferation and regeneration

Cell Proliferation

Volumn 38, Issue 5, 2005, Pages 287-299

  Arendt, E ^a   Ueberham, U ^a   Bittner, R ^a   Gebhardt, R ^a   Ueberham, Elke ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; COLLAGENASE 3; CYCLIN D1; CYCLINE; CYTOKINE; DNA; GELATINASE A; MESSENGER RNA; TETRACYCLINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DNA STRUCTURE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROGENESIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER FIBROSIS; MORPHOMETRICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DEGRADATION; STAINING; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; COLLAGENASES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; REGENERATION; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; MUS MUSCULUS;

EID: 27144558004     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2005.00350.x     Document Type: Article

References (30)

1. Abdel-Aziz G, Lebeau G, Rescan PY, Clement B, Rissel M, Deugnier Y, Campion JP, Guillouzo A (1990) Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. Am. J. Pathol. 137, 1333.
2. Albrecht JH, Hansen LK (1999) Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ. 10, 397.
3. Albrecht JH, Rieland BM, Nelsen CJ, Ahonen CL (1999) Regulation of G(1) cyclin-dependent kinases in the liver: role of nuclear localization and p27 sequestration. Am. J. Physiol. 277, G1207.
4. Clute P, Pines J (1999) Temporal and spatial control of cyclin B1 destruction in metaphase. Nat. Cell Biol. 1, 82.
5. Coqueret O (2002) Linking cyclins to transcriptional control. Gene 299, 35.
6. Gotoh J, Obata M, Yoshie M, Kasai S, Ogawa K (2003) Cyclin D1 over-expression correlates with β-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3β and ERK1/2 in mouse hepatic carcinogenesis. Carcinogenesis 24, 435.
7. Harbour JW, Luo RX, Dei Santi A, Postigo AA, Dean DC (1999) Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell 98, 859.
8. Haruyama T, Ajioka I, Akaike T, Watanabe Y (2000) Regulation and significance of hepatocyte-derived matrix metalloproteinases in liver remodeling. Biochem. Biophys. Res. Commun. 16, 681.
9. Huppertz B, Frank HG, Kaufmann P (1999) The apoptosis cascade - morphological and immunohistochemical methods for its visualization. Anat. Embryol. 200, 1.
10. Hutterer F, Rubin E, Popper H (1964) Mechanism of collagen resorption in reversible hepatic fibrosis. Exp. Mol. Pathol. 86, 215.
11. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ (1998) Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 102, 538.
12. Kim TH, Mars WM, Stolz DB, Michalopoulos GK (2000) Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration. Hepatology 31, 75.
13. Knittel T, Mehde M, Grundmann A, Saile B, Scharf JG, Ramadori G (2000) Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem. Cell Biol. 113, 443.
14. Liu ML, Mars WM, Zarnegar R, Michalopoulos GK (1994) Collagenase pretreatment and the mitogenic effects of hepatocyte growth factor and transforming growth factor-α in adult rat liver. Hepatology 19, 1521.
15. Martin DC, Sanchez-Sweatman OH, Ho AT, Inderdeo DS, Tsao MS, Khokha R (1999) Transgenic TIMP-1 inhibits simian virus 40 T-antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Lab. Invest. 79, 225.
16. Masumoto A, Yamamoto N (1991) Sequestration of a hepatocyte growth factor in extracellular matrix in normal adult rat liver. Biochem. Biophys. Res. Commun. 174, 90.
17. Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U, Edwards DR, Khokha R (2005) Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 41, 857.
18. Morris GF, Mathews MB (1989) Regulation of proliferating cell nuclear antigen during the cell cycle. J. Biol. Chem. 264, 13856.
19. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP (2002) Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J. Biol. Chem. 277, 11069.
20. Nelsen CJ, Rickheim DG, Timchenko NA, Stanley MW, Albrecht JH (2001) Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res. 61, 8564.
21. Nimjee SM, Rusconi CP, Sullenger BA (2005) APTAMERS: an emerging class of therapeutics. Annu. Rev. Med. 56, 555.
22. Nishio T, Iimuro Y, Nitta T, Harada N, Yoshida M, Hirose T, Yamamoto N, Morimoto T, Brenner DA, Yamaoka Y (2003) Increased expression of collagenase in the liver induces hepatocyte proliferation with cytoplasmic accumulation of β-catenin in the rat. J. Hepatol. 38, 468.
23. Rudolph KL, Trautwein C, Kubicka S, Rakemann T, Bahr MJ, Sedlaczek N, Schuppan D, Manns MP (1999) Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats. Hepatology 30, 1159.
24. Schuchmann M, Galle PR (2001) Apoptosis in liver disease. Eur. J. Gastroenterol. Hepatol. 13, 785.
25. Schuppan D, Schmid M, Somasundaram R, Ackermann R, Ruehl M, Nakamura T, Riecken EO (1998) Collagens in the liver extracellular matrix bind hepatocyte growth factor. Gastroenterology 114, 139.
26. Sherr CJ (1996) Cancer cell cycles. Science 274, 1672.
27. Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, Sato H, Seiki M, Ooshima A, Watanabe A (1995) Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 21, 787.
28. Tomomura A, Sawada N, Sattler GL, Kleinman HK, Pitot HC (1987) The control of DNA synthesis in primary cultures of hepatocytes from adult and young rats: interactions of extracellular matrix components, epidermal growth factor, and the cell cycle. J. Cell Physiol. 130, 221.
29. Ueberham E, Low R, Ueberham U, Schönig K, Bujard H, Gebhardt R (2003) Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37, 1067.
30. Ueberham E, Arendt E, Starke M, Bittner R, Gebhardt R (2004) Reduction and expansion of the glutamine synthetase expressing zone in livers from tetracycline controlled TGF-β1 transgenic mice and multiple starved mice. J. Hepatol. 41, 75.